Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
Supporting Files
Public Domain
-
Jul 2016
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of diphtheria.
-
Subjects:
-
Source:Emerg Infect Dis. 22(7):1265-1267.
-
Pubmed ID:27314309
-
Pubmed Central ID:PMC4918160
-
Document Type:
-
Volume:22
-
Issue:7
-
Collection(s):
-
Main Document Checksum:urn:sha256:f8615df961b00dda900760f38faa1846e3e8dab92ca147a968f42dada66f5977
-
Download URL:
-
File Type:
Supporting Files
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases